KYVERNA THERAPEUTICS INC (KYTX) Stock Analyst Ratings
USA - NASDAQ:KYTX - US5019761049 - Common Stock
3.87 USD
-0.04 (-1.02%)
3.87 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 85% to KYTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 18.56. This target is 379.69% above the current price.
KYTX was analyzed by 13 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about KYTX.
In the previous month the buy percentage consensus was at a similar level.
KYTX was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-29 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-20 | William Blair | Initiate | Outperform |
| 2025-05-27 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2025-04-03 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2025-04-01 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-11-20 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2024-11-15 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-10-10 | UBS | Initiate | Buy |
| 2024-09-19 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-08-15 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2024-07-31 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-07-16 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-07-03 | HC Wainwright & Co. | Initiate | Neutral |
| 2024-03-04 | JP Morgan | Initiate | Overweight |
| 2024-03-04 | Morgan Stanley | Initiate | Overweight |